Flurbiprofen

Flurbiprofen
Names
Trade namesAnsaid, Ocufen, Strepfen
Other names(±)-2-fluoro-α-methyl-(1,1'-biphenyl)-4-acetic acid
IUPAC name
  • (RS)-2-(2-fluorobiphenyl-4-yl)propanoic acid
Clinical data
Drug classNonsteroidal anti-inflammatory drugs (NSAIDs)[1]
Main usesBy mouth: Rheumatoid arthritis, ankylosing spondylitis[1]
Eye drop: Decrease pupil constriction, inflammation of the eye[2]
WHO AWaReUnlinkedWikibase error: ⧼unlinkedwikibase-error-statements-entity-not-set⧽
Pregnancy
category
  • AU: B2
  • US: C (Risk not ruled out)
    Routes of
    use
    By mouth
    External links
    AHFS/Drugs.comSystemic: Monograph
    Eye: Monograph
    MedlinePlusa687005
    Pharmacokinetics
    Protein binding> 99%
    MetabolismLiver (CYP2C9)
    Elimination half-life4.7-5.7 hours
    ExcretionKidney
    Chemical and physical data
    FormulaC15H13FO2
    Molar mass244.265 g·mol−1
    3D model (JSmol)
    ChiralityRacemic mixture
    Melting point117 °C (243 °F)
    SMILES
    • Fc2cc(ccc2c1ccccc1)C(C(=O)O)C
    InChI
    • InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18) checkY
    • Key:SYTBZMRGLBWNTM-UHFFFAOYSA-N checkY

    Flurbiprofen is a nonsteroidal anti-inflammatory drugs (NSAIDs) used to treat pain and inflammation.[1][3] By mouth it is used to treat painful periods, rheumatoid arthritis, and ankylosing spondylitis.[1][3] As an eye drop it is used to decrease pupil constriction during eye surgery and inflammation of the eye after surgery.[2]

    Common side effects when taken by mouth include swelling, heart burn, gastrointestinal bleeding, nausea, liver problems, and anxiety.[1] Common side effects when used as an eye drop include burning, dry eyes, and large pupils.[2] Other side effects may include anaphylaxis and heart problems.[1] Use in the second half of pregnancy may harm the baby.[1] It works by blocking COX1 and COX2.[1]

    Flurbiprofen was patented in 1964 and approved for medical use in 1987.[4] It became available as a generic medicaion in 1994.[5] In the United States 100 tablets of 100 mg costs about 66 USD as of 2021.[6] This amount in the United Kingdom costs about £92.[3]

    Medical uses

    Dosage

    It is taken by mouth as 100 mg two to three times per day.[1]

    Side effects

    In October 2020, the U.S. Food and Drug Administration (FDA) required the drug label to be updated for all nonsteroidal anti-inflammatory medications to describe the risk of kidney problems in unborn babies that result in low amniotic fluid.[7][8] They recommend avoiding NSAIDs in pregnant women at 20 weeks or later in pregnancy.[7][8]

    History

    Flurbiprofen was patented in 1964 by Boots UK and approved for medical use in 1987.[4]

    Society and culture

    Cost

    This medication has a cost in the U.S. of $18 (USD) for 15 tablets (100 mg).[9]

    Brand names

    As of 2016 the drug was available worldwide as drops for ophthalmic use and as tablets, both in various strengths, under many brand names which include: Acustop Cataplasma, Adofeed, Anazin, Anflupin, Anorcid, Ansaid, Antadys, Antafen, Antipain, Baenazin, Benactiv, Biprofin, Biprotec, Bro-Z, Brufen, Brufoz, Cebutid, Clinadol, Coryfin, Dispain, Edolfene, Eyeflur, Falken, Fiera, Flu Ro Fen, Flubifix, Flufen, Flugalin, Flupe, Flur di fen, Fluractive, Fluran, Flurbi Pap, Flurbic, Flurbiprofen, Flurbiprofène, Flurbiprofeno, Flurflex, Flurofen, Fluroptic, Fo Bi Pu Luo Fun, Forphen, Fortine, Froben, Frolix, Fubifen, Fubiprofen, Fubofen, Fukon, Fulruban, Furofen, Kai Fen, Kavoflog, Kotton, Lefenine, Majezik, Maprofen, Maxaljin, Maximus, Meiprofen, Neliacan, Nibelon, Nirolex Gola, Ocufen, Ocuflur, Optifen, Orofaringeo, Painil, Profen, Projezik, Ropion, Sigmaprofen, Stayban, Strefen, Strepfen, Strepflam, Strepsils (various formulations), Sulan, Tie Shr Shu, TransAct, Upnon, Urbifen, Yakuban, Zepolas, Zeralgo, Zero-P, and Zeton.[10]

    References

    1. 1 2 3 4 5 6 7 8 9 "Flurbiprofen Monograph for Professionals". Drugs.com. Archived from the original on 28 August 2021. Retrieved 14 December 2021.
    2. 1 2 3 "Flurbiprofen (EENT) Monograph for Professionals". Drugs.com. Archived from the original on 28 January 2021. Retrieved 14 December 2021.
    3. 1 2 3 BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 1186. ISBN 978-0857114105.
    4. 1 2 Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 520. ISBN 9783527607495. Archived from the original on 2020-08-06. Retrieved 2020-10-17.
    5. Approved Drug Products with Therapeutic Equivalence Evaluations (PDF) (36th ed.). FDA. 2014. p. 158. Archived (PDF) from the original on 2016-11-15. Retrieved 2016-11-14.
    6. "Flurbiprofen Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 28 August 2021. Retrieved 14 December 2021.
    7. 1 2 "FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications". U.S. Food and Drug Administration (FDA) (Press release). 15 October 2020. Archived from the original on 16 October 2020. Retrieved 15 October 2020. Public Domain This article incorporates text from this source, which is in the public domain.
    8. 1 2 "NSAIDs may cause rare kidney problems in unborn babies". U.S. Food and Drug Administration. 21 July 2017. Archived from the original on 17 October 2020. Retrieved 15 October 2020. Public Domain This article incorporates text from this source, which is in the public domain.
    9. "Flurbiprofen Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 28 August 2021. Retrieved 30 March 2021.
    10. "Flurbiprofen - International Brand Names". Drugs.com. Archived from the original on 15 November 2016. Retrieved 14 November 2016.
    Identifiers:
    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.